Medication Management

N.B. inks deal with feds to fund access to 4 rare disease drugs with more to come
The $32 million in funding is being allocated through the National Strategy for Drugs for Rare Diseases.
Minor ailment counselling tools: Cold sores
We’re pleased to present the latest in our ongoing series of counselling tools on minor ailments and OTC-related conditions, prepared by students of the Advanced Patient Self-Care elective at the School of Pharmacy at University of Waterloo.

Fertile ground? Exploring the roots of public funding for pharmacy services in Canada

This article, reprinted from Neighbourhood Pharmacy Association of Canada’s Winter Gazette, focuses on the enabler of remuneration by providing an overview of where funding currently stands.
Antipsychotic use has been rising in long-term care homes, but we can do something about it—we’ve done it before

One in four LTC residents in Canada is taking an antipsychotic medication potentially unnecessarily. This number has been increasing over time. It’s time we reversed the trend.
Wegovy and Lambert syrup?

In this opinion piece, a Quebec family physician and blogger shares his amazement at the wonders of pharmaceutical statistical analysis and interpretation.
Ottawa signs $40M deal with Saskatchewan to offer drug coverage for rare diseases

The medicines are Poteligeo, Oxlumo and Epkinly.
When should you reduce the frequency of biological treatments for eczema?

Researchers have identified criteria to predict which patients will likely maintain disease control with less frequent dosing.
A winding journey from pharmacist to family physician

In her career as a pharmacist, Pauwlina Cyca felt she was affecting a lot of people's lives in a positive way. ‘That's part of what drove me to family medicine in the first place.’
Webinar offers opportunity to exchange medication safety incidents with colleagues

The hour-long webinar, set to take place on Jan. 29 at 12 p.m. ET, will provide the opportunity for physicians and pharmacists to share and discuss incident reports, trends and emerging issues in medication safety.
CE: Jackie & Jill - Talking about JAK inhibitors while caring for patients with rheumatic disease (2025)

N.B. inks deal with feds to fund access to 4 rare disease drugs with more to come

Minor ailment counselling tools: Cold sores

Fertile ground? Exploring the roots of public funding for pharmacy services in Canada

Antipsychotic use has been rising in long-term care homes, but we can do something about it—we’ve done it before

Wegovy and Lambert syrup?

Ottawa signs $40M deal with Saskatchewan to offer drug coverage for rare diseases

When should you reduce the frequency of biological treatments for eczema?

A winding journey from pharmacist to family physician

Webinar offers opportunity to exchange medication safety incidents with colleagues

CE: Jackie & Jill - Talking about JAK inhibitors while caring for patients with rheumatic disease (2025)